Vera Therapeutics, Inc. Class A VERA
NASDAQ · United States · Health Technology
$31.54-0.75 (-2.32%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -1.52 | -1.58 | +3.5% | $0 | — | -7.9%$32.89→$30.29 |
| Q1 2026 | 2026-05-07 | -1.69 | -1.26 | -34.1% | — | — | -1.1%$36.60→$36.19 |
| Q4 2025 | 2026-02-26 | -1.39 | -1.27 | -9.4% | — | — | -2.1%$41.68→$40.79 |
| Q3 2025 | 2025-11-05 | -1.26 | -1.20 | -5.0% | — | — | +3.6%$24.35→$25.22 |
| Q2 2025 | 2025-08-05 | -1.20 | -0.62 | -93.5% | — | — | — |
| Q1 2025 | 2025-05-06 | -0.81 | -0.78 | -3.8% | — | — | — |
| Q4 2024 | 2025-02-26 | -0.72 | -0.73 | +1.4% | — | — | — |
| Q1 2024 | 2024-05-08 | -0.56 | -0.56 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.